Using predictive analytics to address social determinants of Health and transportation barriers.
When the healthcare industry and government entities started working in earnest to resolve challenges related to social determinants of health (SDoH)—defined by Healthy People 2030 as economic stability, education access and quality, healthcare access and quality, neighborhood and built environment, and social and community context—the experts soon realized the gravity of the gap in healthcare and everyday services that these factors can present.
As much as 80% of health outcomes are negatively influenced by the ongoing effects of SDoH, according to the Robert Wood Johnson Foundation. Many of those SDoH categories cross lines, and what we as an industry realized is that the blurred lines of SDoH factors can be co-dependent.
But we also recognize that co-existing factors present multiple barriers to care, not only access to care but the equity of care: one of those is access to reliable, convenient transportation.
“Transportation barriers are often cited as barriers to healthcare access,” according to the Journal of Community Health. “Transportation barriers can lead to rescheduled or missed appointments, delayed care and missed or delayed medication use. These consequences may lead to poorer management of chronic illness and thus poorer health outcomes.”
In addition, the same study found that when transportation barriers are eliminated, we have a good chance of improving health access and equity. Underserved populations do a lot of waiting because of a lack of secure, dependable transportation, which impedes good health, well-being and the overall patient experience.
To break down barriers to healthcare and improve health equity, we must ensure dependable and safe transportation to healthcare services, no matter who the rider is or where they live.
A separate Health Affairs analysis found that those with a transportation barrier had a 63% higher risk of readmission within a specific population of high-risk patients.
If we can make a substantive impact on transportation, we have the possibility of improving patient satisfaction, lowering healthcare costs for patients and providers and improving health outcomes.
Predictive Analytics and NEMT Software
One way to get there is by using advanced non-emergency medical transportation (NEMT) software. Low-income patients used 59 million rides for medical appointments in 2015 alone, according to Health Services Insights.
What we need is a transfer of knowledge from other industries. We can apply this transportation knowledge to healthcare, and we can use ideas from the trucking industry, for example, to help build and improve NEMT.
NEMT providers frequently face issues and obstacles caused by significant and continuous traffic on roads and highways. However, we can use various trucking industry concepts and our predictive analytics to make real-time decisions that impact patient trips positively.
Predictive analytics can help us reroute trips on the fly, make and change trips, and significantly decrease the time a patient waits for a ride. We want to mitigate the effects of traffic congestion, accidents, rush-hour traffic and more.
The rising need for mobility, especially in large urban centers, consequently results in congestion, which leads to increased travel times and pollution, according to the Brookings Institute. Many NEMT providers work in urban areas and smaller cities and towns, all of which come with unique traffic challenges.
To close the ride/arrival time gap and thwart elevated congestion levels, we can use patient location and driver location data, using GPS found in smartphones or vehicles, to reroute vehicles immediately to the right place at the right time. In addition to decreasing wait times, we can improve patient satisfaction and the overall ride experience with a more responsive ride management system.
Driving Change with Analytics
By evaluating the elasticity of other quality metrics and determining overall program optimization goals, predictive analytics can be used for pre-dispatch/routing decisions to achieve other key program goals and facilitate high-level strategic investments in member health. These improvements can transform lower-level routine service tasks into automated decisions with human oversight for improved scalability and program control.
We can use predictive analytics to better understand and act on several transportation-related challenges.
Predicting the Future
As more NEMT routes are digitized, and the data is collected and analyzed, it will be easier to transform the NEMT industry and provide patients with an around-the-clock, on-demand, and improved ride registration and trip experience.
The goal, whether you’re a healthcare transportation provider, a driver or a patient, is to meaningfully alter the entire NEMT model by utilizing predictive analytics to create an improved experience for everyone involved because no one wants to wait for a ride any longer than they must.
Differences in Defining “Clinically Meaningful” in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Exploring Key Unmet Needs in Idiopathic Pulmonary Fibrosis
October 4th 2024Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the symptoms, epidemiology diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) in a Managed Healthcare Executive K-Cast video series.
Read More